Global Blue Group
GB
NZ$12.36
Share price
0.14%
Change (1 day)
48.23%
Change (1 year)
Categories
Global Blue Group (GB) - Net assets
Net assets on the balance sheet as of March 2025 : NZ$0.26 Billion
According to Global Blue Group's latest financial reports the company has NZ$0.26 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Global Blue Group - Net assets on balance sheet (from 2020 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-03-31 | $NZ$0.12 B | 1052.36% |
| 2023-03-31 | $NZ$11 M | -103.71% |
| 2022-03-31 | $-NZ$0.3 Billion | 75.61% |
| 2021-03-31 | $-NZ$0.17 Billion | -227.53% |
| 2020-03-31 | $NZ$0.13 B | -7.39% |
| 2019-03-31 | $NZ$0.14 B | -6.21% |
| 2018-03-31 | $NZ$0.15 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | NZ$37.58 B | 14,290.12% | 🇺🇸 USA |
 Stryker Corporation SYK | NZ$35.04 B | 13,318.21% | 🇺🇸 USA |
 Edwards Lifesciences EW | NZ$17.06 B | 6,433.83% | 🇺🇸 USA |
 Medtronic MDT | NZ$80.80 B | 30,836.90% | 🇮🇪 Ireland |
 Johnson & Johnson JNJ | NZ$130.79 B | 49,975.65% | 🇺🇸 USA |